These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2976670)

  • 1. The relationship between pharmacokinetics and pharmacodynamics of enoximone in healthy man.
    Belz GG; Meinicke T; Schäfer-Korting M
    Eur J Clin Pharmacol; 1988; 35(6):631-5. PubMed ID: 2976670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of oral administration of enoximone on cardiac performance, arterial circulation at rest and on the vasoconstrictor effect of local noradrenaline infusions into the human hand vein].
    Breithaupt K; Belz GG; Kempinski S; Schicketanz KH; Dieterich HA
    Z Kardiol; 1991; 80 Suppl 4():15-20. PubMed ID: 1833892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of oral enoximone on cardiac performance, calf arterial blood flow, and constrictor effects of norepinephrine infused into hand veins in humans.
    Breithaupt K; Belz GG; Kempinski S; Schicketanz KH; Dieterich HA
    J Cardiovasc Pharmacol; 1990 Sep; 16(3):349-53. PubMed ID: 1700203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of enoximone during intravenous infusion.
    Winkle RA; Smith NA; Ruder MA; Mead RH; Lebsack C; Bekele T; Kates RE; Rubin J; Okerholm R
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S1-2. PubMed ID: 2145232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology and pharmacokinetics of enoximone.
    Dage RC; Okerholm RA
    Cardiology; 1990; 77 Suppl 3():2-13; discussion 27-33. PubMed ID: 2148277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacology and pharmacokinetics of enoximone].
    Jähnchen E; Trenk D
    Z Kardiol; 1991; 80 Suppl 4():21-6. PubMed ID: 1833893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enoximone. A review of its pharmacological properties and therapeutic potential.
    Vernon MW; Heel RC; Brogden RN
    Drugs; 1991 Dec; 42(6):997-1017. PubMed ID: 1724645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of intravenous enoximone: pharmacodynamics and pharmacokinetics in patients with heart failure.
    Smith NA; Kates RE; Lebsack C; Ruder MA; Mead RH; Bekele T; Okerholm RA; Rubin GM; Winkle RA
    Am Heart J; 1991 Sep; 122(3 Pt 1):755-63. PubMed ID: 1831585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of chronic cardiac insufficiency with intravenous bolus enoximone. Study of a pharmacokinetic-hemodynamic relation].
    Gibelin P; Garraffo R; Sbirrazzuoli V; Lapalus P; Morand P
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():75-81. PubMed ID: 2147839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intravenous enoximone in dialysis patients.
    Fiegel P; Trenk D; Jaehnchen E; Dieterich HA
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S20-3. PubMed ID: 2480480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind crossover comparison of enoximone and placebo in patients with congestive heart failure.
    Choraria SK; Taylor D; Pilcher J
    Circulation; 1987 Dec; 76(6):1307-11. PubMed ID: 2960473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dose-response relation of intravenous enoximone in congestive cardiac insufficiency].
    Lellouche D; Delorme G; Merlet P; Dubois-Randé JL; Duval AM; Tarral A; Bourdarias JP; Vernant P
    Arch Mal Coeur Vaiss; 1988 Sep; 81(9):1107-13. PubMed ID: 2973777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral enoximone pharmacokinetics in patients with congestive heart failure.
    Lima JJ; Leier CV; Holtz L; Sterechele J; Shields BJ; MacKichan JJ
    J Clin Pharmacol; 1987 Sep; 27(9):654-60. PubMed ID: 2960700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enoximone: hemodynamic effect in patients with cardiac insufficiency].
    de Langenhagen B; Bouchoucha H; Scholl JM; Hennetier G; Benacerraf A; Achard F; Bock F
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():19-25. PubMed ID: 2147830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of hemodynamic effects of one-month oral captopril and enoximone treatment for severe congestive heart failure.
    Scriven AJ; Lipkin DP; Anand IS; Sutton GC; Poole-Wilson PA
    Am J Cardiol; 1987 Aug; 60(5):68C-71C. PubMed ID: 2956872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation.
    Khalife K; Zannad F; Brunotte F; Belhadj K; Juilliere Y; Iannascoli F; Gilgenkrantz JM
    Am J Cardiol; 1987 Aug; 60(5):75C-79C. PubMed ID: 2956874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary report of the effects of orally administered enoximone on regional hemodynamics in congestive heart failure.
    Leier CV; Meiler SE; Matthews S; Unverferth DV
    Am J Cardiol; 1987 Aug; 60(5):27C-30C. PubMed ID: 2956864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Postoperative enoximone in coronary surgery. Systemic and coronary hemodynamics and regional systolic function].
    Payen D; Dupuy P; Schurando P; Laborde F
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():13-7. PubMed ID: 2147829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure.
    Installé E; Gonzalez M; Jacquemart JL; Collard P; Roulette F; Pourbaix S; Tremouroux J
    Am J Cardiol; 1987 Aug; 60(5):46C-52C. PubMed ID: 2956868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Suppression of the adrenal cortex by enoximone. A proband study with documentation of the hemodynamic course].
    Sold M; Engelhardt W; Hartung E; Trautner H
    Anaesthesist; 1992 Nov; 41(11):680-4. PubMed ID: 1463155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.